Rizzo M - Search Results

1

Incretins, Pregnancy, and Gestational Diabetes.

Nikolic D, Al-Rasadi K, Al Busaidi N, Al-Waili K, Banerjee Y, Al-Hashmi K, Montalto G, Rizvi AA, Rizzo M, Al-Dughaishi T. Nikolic D, et al. Among authors: rizzo m. Curr Pharm Biotechnol. 2016;17(7):597-602. doi: 10.2174/1389201017666160127110125. Curr Pharm Biotechnol. 2016. PMID: 26813306 Review.

2

Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project.

Barbagallo CM, Cavera G, Sapienza M, Noto D, Cefalù AB, Polizzi F, Onorato F, Rini G, Di Fede G, Pagano M, Montalto G, Rizzo M, Descovich G, Notarbartolo A, Averna MR. Barbagallo CM, et al. Among authors: rizzo m. J Am Coll Nutr. 2002 Dec;21(6):523-9. doi: 10.1080/07315724.2002.10719250. J Am Coll Nutr. 2002. PMID: 12480797

3

The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

Rizzo M, Rizvi AA, Rini GB, Berneis K. Rizzo M, et al. Acta Diabetol. 2009 Mar;46(1):1-11. doi: 10.1007/s00592-008-0057-4. Epub 2008 Oct 17. Acta Diabetol. 2009. PMID: 18925358 Review.

4

Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.

Rizzo M, Berneis K, Altinova AE, Toruner FB, Akturk M, Ayvaz G, Rini GB, Spinas GA, Arslan M. Rizzo M, et al. Diabet Med. 2008 Dec;25(12):1406-11. doi: 10.1111/j.1464-5491.2008.02613.x. Diabet Med. 2008. PMID: 19046238

5

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors.

Rizzo M, Rizvi AA, Spinas GA, Rini GB, Berneis K. Rizzo M, et al. Expert Opin Investig Drugs. 2009 Oct;18(10):1495-503. doi: 10.1517/14728220903241633. Expert Opin Investig Drugs. 2009. PMID: 19758106 Free article. Review.

6

The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly.

Rizzo M, Montalto G, Rizvi AA, Christ ER. Rizzo M, et al. Angiology. 2012 Oct;63(7):492-4. doi: 10.1177/0003319712436578. Epub 2012 Feb 26. Angiology. 2012. PMID: 22371625 No abstract available.

7

The effects of statins on blood pressure: current knowledge and future perspectives.

Rizzo M, Montalto G, Banach M. Rizzo M, et al. Arch Med Sci. 2012 Feb 29;8(1):1-3. doi: 10.5114/aoms.2012.27270. Arch Med Sci. 2012. PMID: 22457664 Free PMC article. No abstract available.

8

Lipid-lowering therapies and achievement of LDL-cholesterol targets.

Rizzo M, Banach M, Montalto G, Mikhailidis DP. Rizzo M, et al. Arch Med Sci. 2012 Sep 8;8(4):598-600. doi: 10.5114/aoms.2012.30281. Arch Med Sci. 2012. PMID: 23056067 Free PMC article. No abstract available.

9

A review of the cardiovascular and anti-atherogenic effects of ghrelin.

Rizzo M, Rizvi AA, Sudar E, Soskic S, Obradovic M, Montalto G, Boutjdir M, Mikhailidis DP, Isenovic ER. Rizzo M, et al. Curr Pharm Des. 2013;19(27):4953-63. doi: 10.2174/1381612811319270018. Curr Pharm Des. 2013. PMID: 23278489 Review.

10

PCSK9 inhibition - a novel mechanism to treat lipid disorders?

Banach M, Rizzo M, Obradovic M, Montalto G, Rysz J, Mikhailidis DP, Isenovic ER. Banach M, et al. Among authors: rizzo m. Curr Pharm Des. 2013;19(21):3869-77. doi: 10.2174/13816128113199990303. Curr Pharm Des. 2013. PMID: 23286435 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,302 results

Search Page